John Moir

John Moir

Auto-generated profile, based on publicly available information

John Moir

HPB Unit, Freeman Hospital, Newcastle upon Tyne, UK

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2021 in Gut
Verified
Journal Article
Open access
PDF file
Sanjay PandanaboyanaSanjay Pandanaboyana
Sanjay Pandanaboyana
JMJohn Moir
John Moir
JLJohn S Leeds
John S Leeds
KOKofi W Oppong
Kofi W Oppong
AKAditya Kanwar
Aditya Kanwar
MNManu Nayar
Manu Nayar
Objective There is emerging evidence that the pancreas may be a target organ of SARS-CoV-2 infection. This aim of this study was to investigate the outcome of patients with acute pancreatitis (AP) and coexistent SARS-CoV-2 infection. Design A prospective international multicentre cohort study including consecutive patients admitted with AP during the current pandemic was undertaken. Primary outcome measure was severity of AP. Secondary outcome measures were aetiology of AP, intensive care unit (ICU) admission, length of hospital stay, local complications, acute respiratory distress syndrome (ARDS), persistent organ failure and 30-day mortality. Multilevel logistic regression was used to compare the two groups. Results 1777 patients with AP were included during the study period from 1 March to 23 July 2020. 149 patients (8.3%) had concomitant SARS-CoV-2 infection. Overall, SARS-CoV-2-positive patients were older male patients and more likely to develop severe AP and ARDS (p<0.001). Unadjusted analysis showed that SARS-CoV-2-positive patients with AP were more likely to require ICU admission (OR 5.21, p<0.001), local complications (OR 2.91, p<0.001), persistent organ failure (OR 7.32, p<0.001), prolonged hospital stay (OR 1.89, p<0.001) and a higher 30-day mortality (OR 6.56, p<0.001). Adjusted analysis showed length of stay (OR 1.32, p<0.001), persistent organ failure (OR 2.77, p<0.003) and 30-day mortality (OR 2.41, p<0.04) were significantly higher in SARS-CoV-2 co-infection. Conclusion Patients with AP and coexistent SARS-CoV-2 infection are at increased risk of severe AP, worse clinical outcomes, prolonged length of hospital stay and high 30-day mortality.

1 September 2015 in Surgical Oncology
Verified
Journal Article
Closed access
JMJohn A.G. Moir
John A.G. Moir
JMJelena Mann
Jelena Mann
SWSteve A. White
Steve A. White

1 December 2014 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
JMJ. Moir
J. Moir
SWS.A. White
S.A. White
JFJ.J. French
J.J. French
PLP. Littler
P. Littler
DMD.M. Manas
D.M. Manas

1 January 2011 in Case Reports in Gastroenterology
Verified
Journal Article
Open access
PDF file
JMJ.A.G. Moir
J.A.G. Moir
GSG. Sen
G. Sen
RSR. Saif
R. Saif
BHB. Haugk
B. Haugk
JFJ.J. French
J.J. French
This report presents the case of a 70-year-old woman with a previous history of a left nephrectomy for renal cell carcinoma (RCC), who developed general malaise and fatigue. Abdominal computed tomography demonstrated an enhancing 6 × 7 cm necrotic lesion in the lower pole of the spleen suggestive of a metastasis. Given the highly suspicious nature of the lesion we proceeded to splenectomy. The tumour did not breach the splenic capsule, and there was no local diaphragmatic involvement. The mass was concluded to be a true metastasis of the original RCC rather than local recurrence of the disease. The causes of isolated solid splenic lesions are wide and varied, however a past or present history of malignancy should lead to a high index of suspicion for a splenic metastasis. We report an extremely unusual case of spread from a RCC.

13 October 2020 in Pancreas
Verified
Journal Article
Closed access
JMJohn A. G. Frcs Moir
John A. G. Frcs Moir
ALAnna Long
Anna Long
BHBeate Haugk
Beate Haugk
JFJeremy J. French
Jeremy J. French
RCRichard M. Charnley
Richard M. Charnley
SWSteve A. White
Steve A. White
Objectives: Pancreatic stellate cells (PSCs) play a key metabolic role within the tumor microenvironment (stroma) of pancreatic ductal adenocarcinoma (PDAC), being glycolytic and associated with protumorigenic acidification from excess lactate. This study investigates the clinical significance of glycolytic enzyme lactate dehydrogenase (LDH) and determines efficacy of the novel pan-LDH inhibitor Galloflavin. Methods: An in vitro Transwell system was adopted for coculture of PSCs and 3 PDAC cell lines (MIA PaCa-2, PANC-1, and BxPC-3). Cells were treated with Galloflavin, and outcomes were analyzed regarding proliferation, apoptosis, lactate production, and glycolytic enzyme protein expression. Immunohistochemical staining for lactate dehydrogenase B (LDHB) was performed on 59 resected PDAC tumors annotated for clinical outcome. Results: Galloflavin reduced PDAC proliferation in monoculture (P < 0.01); however, in co-culture with PSCs, an antiproliferative effect was only evident in PANC-1 (P = 0.001). An apoptotic effect was observed in MIA PaCa-2 and BxPC-3 in coculture (P < 0.05). A reduction in media lactate was observed in coculture (P < 0.01) with PSCs. Immunohistochemistry revealed stromal and tumoral LDHB expression had no impact on survival. Conclusions: Galloflavin has the potential to neutralize the acidic PDAC microenvironment and thereby reduce tumor invasiveness and metastasis. Patients with lower LDHB expression are more likely to be beneficial responders.

24 October 2024 in British Journal of Radiology
Verified
Journal Article
Open access
PDF file
CCCarmelo Corallo
Carmelo Corallo
AAAbdullah Saad Al-Adhami
Abdullah Saad Al-Adhami
NJNigel Jamieson
Nigel Jamieson
JVJuan Valle
Juan Valle
GRGanesh Radhakrishna
Ganesh Radhakrishna
RAR. Albazaz
R. Albazaz
Pancreatic ductal adenocarcinoma continues to have a poor prognosis, although recent advances in neoadjuvant treatments (NATs) have provided some hope. Imaging assessment of suspected tumours can be challenging and requires a specific approach, with pancreas protocol CT being the primary imaging modality for staging with other modalities used as problem-solving tools to facilitate appropriate management. Imaging assessment post NAT can be particularly difficult due to a current lack of robust radiological criteria to predict response and differentiate treatment induced fibrosis/inflammation from residual tumour. This review aims to provide an update of pancreatic ductal adenocarcinoma with particular focus on three points: tumour staging pre- and post-NAT including vascular assessment, structured reporting with introduction of the PAncreatic Cancer reporting Template—UK (PACT-UK) radiology template, and the potential future role of artificial intelligence in the diagnosis and staging of pancreatic cancer.